Table 1 Clinical features of the study population(N = 112)
Parameters | Group A(n = 68) | Group B(n = 44) | P value |
|---|---|---|---|
Age (years), mean ± SD | 60 ± 11 | 49 ± 13 | 0.217 |
Female/Male, No. (%) | 41(60.3)/27(39.7) | 26(59.1)/18(40.9) | 0.899 |
Volume of hemoptysis(ml/d), No. (%) | 0.460 | ||
< 100 ml | 32(47.0) | 15(34.1) | |
100—300 ml | 25(36.8) | 14(31.8) | |
> 300 ml | 18(26.4) | 15(34.1) | |
History of smoking, No. (%) | 27(39.7) | 23(52.3) | 0.191 |
Comorbidities, No. (%) | 0.679 | ||
Hypertension | 9(13.2) | 7(15.9) | |
Hepatitis | 3(4.4) | 1(2.2) | |
Cerebral infarction | 2(2.9) | 3(6.8) | |
Diabetes mellitus | 4(5.9) | 4(9.1) | |
The number of lung segments involved | 3(1–5) | 6(2–8) | 0.151 |
Bronchial dilatation severity score | 1.9(0.8–2.5) | 2.1(1.8–2.5) | 0.072 |
Bronchiectasis type, No. (%) | 0.112 | ||
Columnar | 11(16.2) | 6(13.6) | |
Varicose | 39(57.4) | 18(40.9) | |
Cystic | 18(26.5) | 20(45.6) |